Day: November 14, 2022

DENVER, Nov. 14, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported company highlights and financial results for the nine months ended September 30, 2022. Company Highlights In 2022, Mydecine continued to define its focus and clinical trial execution strategy. The Company reached several milestones with the goal to become an efficiently operated biotechnology company. Of significant note, Mydecine announced several advancements in drug development including first and second-generation drug candidates. The Company has identified and pursued the indications that management believes will be most promising from the view of treating...

Constant currency Net Revenues Increased by 15% year-over-year in the 9M22 and by 11% in the 3Q22, signaling a strong demand across our businesses MIAMI and BARRANQUILLA, Colombia, Nov. 14, 2022 (GLOBE NEWSWIRE) — Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its financial results for the three months ended September 30, 2022 (“3Q22”) and the nine months ended September 30, 2022 (“9M22”). “Demand remains robust for RX and consumer health products as well as for all our CDMO products, and gross margin remained strong despite the challenging macro scenario we have been facing. We have continued to invest and prepare the company for the organic and inorganic growth that is about to come, and we expect to see continued revenue growth and improved...

HOUSTON, Nov. 14, 2022 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the third quarter 2022. Key HighlightsNew volumes from 2022 capital program driving production growth – ~8% increase in average daily production over second quarter 2022 Approximately 34% increase in Adjusted EBITDA over second quarter 2022 Improved realized pricing – ~11% increase in realized crude oil prices despite ~15% decline in average crude oil prices over second quarter 2022 Most recent three well pad began flowing back during second week of October, raising total to 8 wells put online in 2022 Completed Third Bone Spring test with promising early results – production in line with Wolfcamp well performance Construction of acid gas treating facility on...

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today reported financial results for the third quarter of 2022 and provided a corporate update. SZN-1326 UpdateSurrozen announced today that it voluntarily paused enrollment in the single ascending dose (SAD) portion of the Company’s Phase 1 clinical trial evaluating SZN-1326 in healthy volunteers following the observation of treatment-related adverse events. Several subjects experienced asymptomatic liver transaminase elevations, including three subjects with grade 3 ALT and AST elevations. There were no corresponding increases in total bilirubin nor any changes in liver function markers...

WALL, N.J., Nov. 14, 2022 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) and large-scale identity solutions, featuring Identity-Bound Biometrics (IBB), today reported results for its third quarter ended September 30, 2022 (Q3’22). BIO-key will host an investor call tomorrow at 10:00 a.m. ET (details below). Q3 Highlights:Q3’22 revenues rose 6% to $1.4M vs. Q3’21 and year-to-date revenues increased 26% to $5.3M, with increased software license and service fees which were partially offset by lower hardware revenue in both 2022 periods. BIO-key expanded its global footprint with enterprise customers including a Dutch-based multi-national conglomerate and a leading Saudi Arabia healthcare procurement provider. Broadened partner...

MONTREAL, Nov. 14, 2022 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or “the Corporation”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for the first quarter ended September 30, 2022, and unveiled its 5-year strategic plan. All amounts in this press release are in Canadian dollars, unless otherwise stated.Q1 HIGHLIGHTS   STRATEGIC PLAN HIGHLIGHTS     • Revenues from customers grew 52% to $27.1 million vs Q1-2022• For Q1-2023, Gross margin was 11.6%, an increase of 860 bps over Q1-2022, and Adjusted EBITDA* totaled -$2 million, an improvement of $1.8 million over Q1-2022• Total liquidity of $49.1 million as at September 30, 2022, including cash and cash equivalents of $42.8 million• Total long-term debt of $9 million as at September 30, 2022• For financial year 2023,...

GEORGE TOWN, Grand Cayman, Nov. 14, 2022 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer and operator of advanced water supply and treatment plants, reported results for the third quarter and nine months ended September 30, 2022. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call at 11:00 a.m. Eastern time tomorrow to discuss the results (see dial-in information below). Third Quarter 2022 Financial HighlightsTotal revenue increased 53% to $25.1 million. Retail revenue increased 20% to $6.3 million. Bulk revenue increased 26% to $8.7 million. Services revenue increased 172% to $8.7 million. Net income from continuing operations attributable to company stockholders was $824,000 or $0.05 per share. Paid quarterly...

LAS VEGAS, Nov. 14, 2022 (GLOBE NEWSWIRE) — Galaxy Gaming, Inc. (OTCQB: GLXZ), a developer and distributor of casino table games and enhanced systems for land-based casinos and iGaming content, announced today its financial results for the quarter and nine months ended September 30, 2022. Financial Highlights Q3 2022 vs. Q3 2021Revenue increased 12% to $5,907K Adjusted EBITDA decreased 5% to $2,350K Net loss of $(699)K vs. net income of $874K9 Months 2022 vs. 9 Months 2021Revenue increased 22% to $17,502K Adjusted EBITDA increased 17% to $7,382K Net loss of $(1,828)K vs. net income of $1,513KBalance Sheet Changes (vs. December 31, 2021)Cash increased 20% to $19,275K Total long-term debt1 (gross) decreased to $59,550K from $60,500K Stockholders’ deficit increased to $(18,506)K from $(17,286)KExecutive Comments “Despite...

Comprehensive Earnings Call Preview Highlights:$9 million in new gross proceeds from recent financings extends runway, $5 million of which from unsecured, non-dilutive, 18-month, non-convertible, 9% fixed interest loan; Massive cost-cutting measures recently completed reduces monthly operating costs, plus senior executives and Board accept 25% reduction in cash component of compensation; Nasdaq confirmed new 6-month extension to regain share price compliance; Prominent international M&A and strategic advisory firm Alantra engaged by Board to assist in evaluating strategic opportunities; MARKET.live livestream shopping platform growth accelerating, 76,000 shoppers acquired in first 90 days, approx. 500 approved sellers active or activating on the platform; popular creators onboarding for new Creator program; 250 confirmed livestream...